Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?

• Main Authors: Matteo Tacelli (Author), Ciro Celsa (Author), Bianca Magro (Author), Aurora Giannetti (Author), Grazia Pennisi (Author), Federica Spatola (Author), Salvatore Petta (Author)
• Format: Book
• Published: MDPI AG, 2018-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease in Western countries, accounting for 20⁻30% of general population and reaching a prevalence of 55% in patients with type 2 diabetes mellitus (T2DM). Insulin resistance plays a key role in pathogenic...